AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 213186 — intervention group
Group type: COMPARATOR
Intervention: Comparable groups of patients with squamous carcinoma
Number of subjects: 75
Study 31338688 — intervention group
Group type: COMPARATOR
Intervention: SAGE-217 (0.25 to 66 mg single dose)
Number of subjects: 108
Study 31338688 — intervention group
Group type: COMPARATOR
Intervention: SAGE-217 (15, 30, or 35 mg once daily for 7 days)
Number of subjects: 108
Study 31338688 — intervention group
Group type: COMPARATOR
Intervention: SAGE-217
Number of subjects: 108
Study 31338688 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 31175210 — intervention group
Group type: EXPERIMENTAL
Intervention: e-STI testing and results service
Number of subjects: 528
Study 28060921 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Care Group (ICG)
Number of subjects: 0
Study 28060921 — intervention group
Group type: COMPARATOR
Intervention: Usual Care Group (UCG)
Number of subjects: 0
Study 25502343 — intervention group
Group type: EXPERIMENTAL
Intervention: Antegrade intramedullary pinning
Number of subjects: 46
Study 25502343 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous retrograde intramedullary pinning
Number of subjects: 46
Study 24196337 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 3.75%
Number of subjects: 479
Study 24196337 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 2.5%
Number of subjects: 479
Study 24196337 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (Control)
Number of subjects: 479
Study 22687548 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation condition including the Posit Science Brain Fitness auditory training program with weekly Neuropsychological and Educational Approach to Remediation (NEAR) 'bridging groups'
Number of subjects: 53
Study 22687548 — intervention group
Group type: COMPARATOR
Intervention: Computer games and weekly healthy lifestyles groups (control condition)
Number of subjects: 53
Study 19050635 — intervention group
Group type: EXPERIMENTAL
Intervention: NIPPVf (face mask)
Number of subjects: 90
Study 19050635 — intervention group
Group type: COMPARATOR
Intervention: NIPPVn (nasal mask)
Number of subjects: 90
Study 17514524 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin adhesive (Quixil) (n = 42)
Number of subjects: 81
Study 17514524 — intervention group
Group type: COMPARATOR
Intervention: Vicryl sutures (n = 39)
Number of subjects: 81
Study 15528583 — intervention group
Group type: EXPERIMENTAL
Intervention: Wireless networked mobile computer (MC)
Number of subjects: 10
Study 11851739 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A) injections (up to 4.0 U BOTOX/kg/muscle, 16 U/kg/body weight every 6 months) plus SWASH brace
Number of subjects: 39
Study 11851739 — intervention group
Group type: COMPARATOR
Intervention: Control group (clinical best practice physiotherapy without hip abduction bracing)
Number of subjects: 39
Study 11851739 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (BTX‐A/SWASH)
Number of subjects: 39
Study 9611669 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (10 +/- 2.5 mg)
Number of subjects: 335
Study 9611669 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (15 +/- 2.5 mg)
Number of subjects: 335
Study 9611669 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol (10-20 mg)
Number of subjects: 335
Study 8555592 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma Exchange (PE)
Number of subjects: 22
Study 8555592 — intervention group
Group type: COMPARATOR
Intervention: Plasma Perfusion (PP)
Number of subjects: 22
Study 3295299 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon
Number of subjects: 18
Study 3295299 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 29735019 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA+DHA therapy (2.5 g/d)
Number of subjects: 35
Study 29735019 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 35
Study 27195316 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 78
Study 27195316 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 23892501 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei SD1
Number of subjects: 40
Study 23892501 — intervention group
Group type: COMPARATOR
Intervention: Standard milk powder (placebo)
Number of subjects: 40
Study 22656676 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric ropivacaine (11.25mg) + 2mL dextrose (5mg.mL(‐1))
Number of subjects: 60
Study 22656676 — intervention group
Group type: COMPARATOR
Intervention: Hypobaric ropivacaine (11.25mg) + 2mL distilled water
Number of subjects: 60
Study 19732091 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin
Number of subjects: 68
Study 19732091 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse Dexamethasone
Number of subjects: 68
Study 19732091 — intervention group
Group type: COMPARATOR
Intervention: Control (Standard Critical Care)
Number of subjects: 68
Study 19732091 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Mortality
Number of subjects: 68
Study 19732091 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum Bilirubin Level
Number of subjects: 68
Study 18729814 — intervention group
Group type: EXPERIMENTAL
Intervention: Carnosine (beta‐alanyl‐L‐histidine) as a food additive
Number of subjects: 0
Study 15986953 — intervention group
Group type: EXPERIMENTAL
Intervention: IRM
Number of subjects: 45
Study 15986953 — intervention group
Group type: EXPERIMENTAL
Intervention: Coltosol
Number of subjects: 45
Study 15986953 — intervention group
Group type: EXPERIMENTAL
Intervention: CLIP
Number of subjects: 45
Study 15986953 — intervention group
Group type: COMPARATOR
Intervention: Ag-IRM
Number of subjects: 45
Study 15986953 — intervention group
Group type: COMPARATOR
Intervention: Ag-CLIP
Number of subjects: 45
Study 15986953 — intervention group
Group type: COMPARATOR
Intervention: Co-IRM
Number of subjects: 45
Study 15986953 — intervention group
Group type: COMPARATOR
Intervention: Co-CLIP
Number of subjects: 45
Study 12414399 — intervention group
Group type: EXPERIMENTAL
Intervention: HOTL (daily wear)
Number of subjects: 168
Study 12414399 — intervention group
Group type: COMPARATOR
Intervention: Control lens (daily wear)
Number of subjects: 168
Study 12414399 — intervention group
Group type: EXPERIMENTAL
Intervention: HOTL (extended wear)
Number of subjects: 168
Study 12414399 — intervention group
Group type: COMPARATOR
Intervention: Control lens (extended wear)
Number of subjects: 168
Study 12414399 — intervention group
Group type: EXPERIMENTAL
Intervention: HOTL (extended wear, 6 nights)
Number of subjects: 168
Study 12414399 — intervention group
Group type: EXPERIMENTAL
Intervention: HOTL (extended wear, 30 nights)
Number of subjects: 168
Study 12414399 — intervention group
Group type: EXPERIMENTAL
Intervention: Both lenses (daily wear)
Number of subjects: 168
Study 12414399 — intervention group
Group type: EXPERIMENTAL
Intervention: Both lenses (extended wear)
Number of subjects: 168
Study 10359479 — intervention group
Group type: EXPERIMENTAL
Intervention: ipsapirone 0.3 mg/kg
Number of subjects: 36
Study 10359479 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 36
Study 8961905 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfasalazine (SSZ) at a dosage of 2,000 mg/day
Number of subjects: 264
Study 8961905 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264
Study 8961905 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfasalazine (SSZ)
Number of subjects: 264
Study 1782977 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal nitroglycerin every 4 hours
Number of subjects: 29
Study 1782977 — intervention group
Group type: COMPARATOR
Intervention: Intravenous nitroglycerin for 24 hours
Number of subjects: 29
Study 6293720 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime perioperatively
Number of subjects: 114
Study 6293720 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime perioperatively and for 24 hours postoperatively
Number of subjects: 114
Study 6293720 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin perioperatively and for 24 hours postoperatively
Number of subjects: 114
Study 30426254 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoperistaltic ileocolic anastomosis (ISO)
Number of subjects: 108
Study 30426254 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiperistaltic ileocolic anastomosis (ANTI)
Number of subjects: 108
Study 28790816 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management education program (SMEP)
Number of subjects: 0
Study 25387256 — intervention group
Group type: EXPERIMENTAL
Intervention: Single RFA session (group A; n = 42)
Number of subjects: 84
Study 25387256 — intervention group
Group type: COMPARATOR
Intervention: Follow-up (group B; n = 42)
Number of subjects: 84
Study 24500157 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete weight restoration (BMI ≥ 18.5) in patients with AN
Number of subjects: 50
Study 24500157 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline BSI-GSI score
Number of subjects: 50
Study 24500157 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 50
Study 23011771 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 µg once-daily
Number of subjects: 2739
Study 19670402 — intervention group
Group type: EXPERIMENTAL
Intervention: First night cough recording
Number of subjects: 25
Study 19670402 — intervention group
Group type: EXPERIMENTAL
Intervention: Second night cough recording
Number of subjects: 25
Study 19670402 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of csec/hr with FEV1%pred on second night
Number of subjects: 25
Study 19670402 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of csec/hr with FEF(75) %pred on second night
Number of subjects: 25
Study 19670402 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of bronchiectasis score with mean csec/hr of both nights
Number of subjects: 25
Study 19670402 — intervention group
Group type: EXPERIMENTAL
Intervention: Cough frequency during first hour of sleep
Number of subjects: 25
Study 17178505 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic Endodontic Technology (AET) system
Number of subjects: 40
Study 17178505 — intervention group
Group type: COMPARATOR
Intervention: ProTaper instruments
Number of subjects: 40
Study 15134695 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamate (1 M) injection into the MAR or right SP
Number of subjects: 19
Study 15134695 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline injection into the MAR or SP
Number of subjects: 19
Study 11157009 — intervention group
Group type: COMPARATOR
Intervention: FEC 50 (fluorouracil 500 mg/m2, epirubicin 50 mg/m2, cyclophosphamide 500 mg/m2)
Number of subjects: 565
Study 11157009 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC 100 (fluorouracil 500 mg/m2, epirubicin 100 mg/m2, cyclophosphamide 500 mg/m2)
Number of subjects: 565
Study 11157009 — intervention group
Group type: COMPARATOR
Intervention: FEC 50
Number of subjects: 565
Study 11157009 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC 100
Number of subjects: 565
Study 9579818 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac lesions
Number of subjects: 157
Study 9579818 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest socioeconomic status
Number of subjects: 157
Study 9579818 — intervention group
Group type: EXPERIMENTAL
Intervention: Pericardial effusion
Number of subjects: 157
Study 9579818 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher CD4 count
Number of subjects: 157
Study 9579818 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilated cardiomyopathy
Number of subjects: 157
Study 9579818 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac mass/volume ratio, body temperature, deceleration time, body mass index, socio‐economic status
Number of subjects: 157
Study 9579818 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart involvement
Number of subjects: 157
Study 7991067 — intervention group
Group type: EXPERIMENTAL
Intervention: sulpiride
Number of subjects: 0
Study 7991067 — intervention group
Group type: EXPERIMENTAL
Intervention: paroxetine
Number of subjects: 0
Study 2522008 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (2.5 to 10 mg qd, mean 9 mg/d)
Number of subjects: 91
Study 2522008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 2522008 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 91
Study 27704326 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth Familias Unidas intervention
Number of subjects: 113
Study 27146793 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum (sugar-free gum for at least 10 minutes, four times per day on days 1-5)
Number of subjects: 402
Study 27146793 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative care
Number of subjects: 402
Study 27146793 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum
Number of subjects: 402
Study 24779067 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumo 23 vaccination
Number of subjects: 200
Study 24779067 — intervention group
Group type: COMPARATOR
Intervention: Unvaccinated
Number of subjects: 200
Study 23024150 — intervention group
Group type: EXPERIMENTAL
Intervention: Mosaic-type osteochondral autologous transplantation (OAT)
Number of subjects: 60
Study 23024150 — intervention group
Group type: COMPARATOR
Intervention: Microfracture (MF)
Number of subjects: 60
Study 20513982 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean peak systolic velocity of the superior thyroid artery (STA‐PSV) measured by ultrasonography in untreated Graves' disease (GD) patients.
Number of subjects: 161
Study 20513982 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean peak systolic velocity of the superior thyroid artery (STA‐PSV) measured by ultrasonography in treated Graves' disease (GD) patients.
Number of subjects: 161
Study 20513982 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean peak systolic velocity of the superior thyroid artery (STA‐PSV) measured by ultrasonography in destructive thyroiditis (DT) patients.
Number of subjects: 161
Study 20513982 — intervention group
Group type: COMPARATOR
Intervention: Receiver operating characteristic curves of the STA‐PSV values.
Number of subjects: 161
Study 17573688 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental therapy
Number of subjects: 0
Study 17573688 — intervention group
Group type: COMPARATOR
Intervention: Prospective control
Number of subjects: 0
Study 15217778 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led intervention
Number of subjects: 153
Study 15217778 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 153
Study 11447800 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound dressing applied after 48 hours
Number of subjects: 100
Study 11447800 — intervention group
Group type: COMPARATOR
Intervention: No wound dressing applied after 48 hours
Number of subjects: 100
Study 9728984 — intervention group
Group type: EXPERIMENTAL
Intervention: LCPUFA-supplemented formula
Number of subjects: 44
Study 9728984 — intervention group
Group type: COMPARATOR
Intervention: No-LCPUFA formula
Number of subjects: 44
Study 9160549 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 44
Study 9160549 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 44
Study 9160549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 2525326 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil (20 mg)
Number of subjects: 20
Study 31207030 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg once daily
Number of subjects: 102
Study 31207030 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 28416247 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive cardiac resynchronization therapy (aCRT)
Number of subjects: 199
Study 28416247 — intervention group
Group type: COMPARATOR
Intervention: Echo-optimized bi-ventricular CRT (control)
Number of subjects: 199
Study 26147315 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain Injury Family Intervention
Number of subjects: 108
Study 26147315 — intervention group
Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 108
Study 23805219 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity program (3-month standardized program led by specialists)
Number of subjects: 362
Study 23805219 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 362
Study 21507028 — intervention group
Group type: EXPERIMENTAL
Intervention: DNK333 25 mg b.d.
Number of subjects: 315
Study 21507028 — intervention group
Group type: EXPERIMENTAL
Intervention: DNK333 100 mg b.d.
Number of subjects: 315
Study 21507028 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 315
Study 21507028 — intervention group
Group type: EXPERIMENTAL
Intervention: DNK333 25 mg b.d. (Trial 2)
Number of subjects: 315
Study 21507028 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Trial 2)
Number of subjects: 315
Study 19690341 — intervention group
Group type: COMPARATOR
Intervention: Advice leaflet
Number of subjects: 389
Study 19690341 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengthening exercises
Number of subjects: 389
Study 19690341 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 389
Study 19690341 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention plus strengthening exercises
Number of subjects: 389
Study 17021083 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose alpha2b interferon (6 million units/day) plus ribavirin (600 to 800 mg/day)
Number of subjects: 97
Study 17021083 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin (600 to 800 mg/day)
Number of subjects: 97
Study 17021083 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose alpha2b interferon plus ribavirin
Number of subjects: 97
Study 15663456 — intervention group
Group type: EXPERIMENTAL
Intervention: New supply air filter at high ventilation rate (80% of total airflow)
Number of subjects: 26
Study 15663456 — intervention group
Group type: EXPERIMENTAL
Intervention: Used supply air filter at high ventilation rate (80% of total airflow)
Number of subjects: 26
Study 15663456 — intervention group
Group type: EXPERIMENTAL
Intervention: New supply air filter at low ventilation rate (8% of total airflow)
Number of subjects: 26
Study 15663456 — intervention group
Group type: EXPERIMENTAL
Intervention: Used supply air filter at low ventilation rate (8% of total airflow)
Number of subjects: 26
Study 15663456 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing outdoor air supply rate with new filter
Number of subjects: 26
Study 15663456 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing outdoor air supply rate with used filter
Number of subjects: 26
Study 15663456 — intervention group
Group type: EXPERIMENTAL
Intervention: Replacing used filter with a clean filter
Number of subjects: 26
Study 15663456 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions on SBS symptoms and environmental perceptions
Number of subjects: 26
Study 10981565 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous acyclovir (10 mg/kg three times daily for 9 days) + prednisolone (60 mg per day with progressive reduction for 21 days)
Number of subjects: 600
Study 10981565 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia (6-12 ml bupivacaine (0.25%) every 6-8 or 12 h) + methylprednisolone (40 mg every 3-4 days by epidural catheter for 7 to 21 days)
Number of subjects: 600
Study 9049576 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (7.5 mg/kg per dose)
Number of subjects: 0
Study 9049576 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (10 mg/kg/dose)
Number of subjects: 0
Study 9049576 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol (10 mg/kg per dose)
Number of subjects: 0
Study 8325065 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral theophylline (400 mg for 2 weeks, followed by 600 mg for 2 weeks)
Number of subjects: 12
Study 8325065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3793027 — intervention group
Group type: EXPERIMENTAL
Intervention: Axillary extract from donor males
Number of subjects: 0
Study 3793027 — intervention group
Group type: COMPARATOR
Intervention: Blank/ethanol applications
Number of subjects: 0
Study 30172428 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 109
Study 30172428 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 109
Study 30172428 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Training (HIIT + MICT)
Number of subjects: 109
Study 30172428 — intervention group
Group type: COMPARATOR
Intervention: Control (no training)
Number of subjects: 109
Study 26943113 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Orientation to Daily Occupational Performance (CO‐OP)
Number of subjects: 35
Study 26943113 — intervention group
Group type: COMPARATOR
Intervention: Usual occupational therapy
Number of subjects: 35
Study 24690533 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed explanatory primer letter designed to encourage research participation
Number of subjects: 1062
Study 24690533 — intervention group
Group type: COMPARATOR
Intervention: No primer letter
Number of subjects: 1062
Study 22401286 — intervention group
Group type: EXPERIMENTAL
Intervention: 80/20 prior knowledge cue
Number of subjects: 0
Study 22401286 — intervention group
Group type: COMPARATOR
Intervention: 50/50 prior knowledge cue
Number of subjects: 0
Study 22401286 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain activity in dorsolateral pFC, inferior frontal junction, anterior insula, inferior parietal lobule, intraparietal sulcus, head of the caudate, posterior cingulate cortex, and fusiform gyrus
Number of subjects: 0
Study 22401286 — intervention group
Group type: EXPERIMENTAL
Intervention: Fronto-parietal and anterior insula ROIs
Number of subjects: 0
Study 20617227 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite resin cement
Number of subjects: 3
Study 20617227 — intervention group
Group type: EXPERIMENTAL
Intervention: Acrylic/urethane cement
Number of subjects: 3
Study 20617227 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc oxide eugenol cement
Number of subjects: 3
Study 19000203 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback from a same-gender peer
Number of subjects: 58